Price T Rowe Associates Inc Trans Medics Group, Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 293,466 shares of TMDX stock, worth $23.7 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
293,466
Previous 330,434
11.19%
Holding current value
$23.7 Million
Previous $49.8 Million
7.42%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding TMDX
# of Institutions
398Shares Held
31.9MCall Options Held
466KPut Options Held
286K-
Vanguard Group Inc Valley Forge, PA3.6MShares$290 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$213 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL1.44MShares$116 Million2.22% of portfolio
-
State Street Corp Boston, MA1.27MShares$103 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.09MShares$88.2 Million0.03% of portfolio
About TransMedics Group, Inc.
- Ticker TMDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,831,400
- Market Cap $2.57B
- Description
- TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...